126 related articles for article (PubMed ID: 11367376)
21. Ganciclovir: approved and investigational uses for the treatment of cytomegalovirus retinitis.
MacArthur RB
Mt Sinai J Med; 1990 Nov; 57(6):378-80. PubMed ID: 1964198
[No Abstract] [Full Text] [Related]
22. CMV drug approved.
Treat Rev; 1995 Nov; (no 20):5. PubMed ID: 11363026
[TBL] [Abstract][Full Text] [Related]
23. Drug delivery system for AIDS-related disease prevents blindness.
J Ophthalmic Nurs Technol; 1992; 11(3):131. PubMed ID: 1317927
[No Abstract] [Full Text] [Related]
24. [Oral ganciclovir for the prevention of illnesses caused by CMV].
Vianna G
Sidahora; 1995; ():33-4. PubMed ID: 11362479
[TBL] [Abstract][Full Text] [Related]
25. Guide to CMV management.
Cheng B
PI Perspect; 1996 Apr; (no 18):13-4. PubMed ID: 11363508
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus retinitis complicated by optic neuropathy: a longitudinal study.
Harkins T; Maino JH
J Am Optom Assoc; 1992 Jan; 63(1):21-7. PubMed ID: 1316391
[TBL] [Abstract][Full Text] [Related]
27. Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.
Monforte V; Román A; Gavaldà J; Bravo C; Gispert P; Pahissa A; Morell F
Transplant Proc; 2005 Nov; 37(9):4039-42. PubMed ID: 16386621
[TBL] [Abstract][Full Text] [Related]
28. Use of ganciclovir in the treatment of cytomegalovirus infections.
Henderson JR
Br J Clin Pract; 1989 Jul; 43(7):233-7. PubMed ID: 2557071
[TBL] [Abstract][Full Text] [Related]
29. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
30. Treatment review.
Treat Rev; 1995 Jan; (no 16):5. PubMed ID: 11362290
[TBL] [Abstract][Full Text] [Related]
31. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
[TBL] [Abstract][Full Text] [Related]
32. Low frequency maintenance ganciclovir for cytomegalovirus retinitis.
Hall AJ; Jennens ID; Lucas CR; MacLean H; Sandland AM
Scand J Infect Dis; 1991; 23(1):43-6. PubMed ID: 1851324
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus retinitis treated with ganciclovir in a renal transplant recipient.
Horng IH; Chen MS; Lee PH; Chen YC; Lee CS; Hou PK
Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1152-5. PubMed ID: 2561486
[TBL] [Abstract][Full Text] [Related]
34. [Adult T cell leukemia with cytomegalovirus retinitis].
Mori N; Ura K; Murakami S; Ogawa R; Wake A; Nagata K; Sato T; Tsukada J; Nakata K; Misago M
Rinsho Ketsueki; 1992 Apr; 33(4):537-41. PubMed ID: 1318431
[TBL] [Abstract][Full Text] [Related]
35. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group.
Spector SA; Weingeist T; Pollard RB; Dieterich DT; Samo T; Benson CA; Busch DF; Freeman WR; Montague P; Kaplan HJ
J Infect Dis; 1993 Sep; 168(3):557-63. PubMed ID: 8394858
[TBL] [Abstract][Full Text] [Related]
36. CMV encephalitis during ganciclovir therapy of CMV retinitis.
Schwarz TF; Loeschke K; Hanus I; Jäger G; Feiden W; Stefani FH
Infection; 1990; 18(5):289-90. PubMed ID: 2177454
[TBL] [Abstract][Full Text] [Related]
37. CMV news.
Posit Aware; 1996; 7(1):5-6. PubMed ID: 11363124
[TBL] [Abstract][Full Text] [Related]
38. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
Murray BM; Subramaniam S
Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
[TBL] [Abstract][Full Text] [Related]
39. Long-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients.
Weisenthal RW; Sinclair SH; Frank I; Rubin DH
Br J Ophthalmol; 1989 Dec; 73(12):996-1001. PubMed ID: 2558708
[TBL] [Abstract][Full Text] [Related]
40. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]